---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-025365"
form_type: "8-K"
ticker: "ABT"
cik: "0000001800"
company_name: "ABBOTT LABORATORIES"
filed_at: "2026-04-16T23:59:59+00:00"
generated_at: "2026-05-15T05:50:43.027807+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Abbott Q1 adj. EPS $1.15, +6% YoY; acquires Exact Sciences; FY guidance $5.38-$5.58

## Summary
- Q1 GAAP diluted EPS $0.61; adjusted diluted EPS $1.15 (+6% YoY).
- Q1 sales $11.16B, reported +7.8%, comparable +3.7%.
- Completed Exact Sciences acquisition March 23; adds $0.20 dilution to FY EPS guidance.
- FY2026 guidance: comparable sales growth 6.5%-7.5%; adjusted EPS $5.38-$5.58.
- Medical Devices +8.5% comparable; Diabetes CGM +7.6% comparable; Nutrition -7.7% comparable.

## SEC filing metadata
- accession: 0001628280-26-025365
- form_type: 8-K
- ticker: ABT
- cik: 0000001800
- company_name: ABBOTT LABORATORIES
- filed_at: 2026-04-16T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1800/000162828026025365/0001628280-26-025365-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1800/000162828026025365/abt-20260416.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-025365
- JSON: https://secwatch.observer/filing/0001628280-26-025365.json
- Plain text: https://secwatch.observer/filing/0001628280-26-025365.txt

## Key facts
- Earnings Releases
  ABBOTT LABORATORIES updated its first quarter ended March 31, 2026 guidance (reaffirmed).
  - Period: first quarter ended March 31, 2026
  - Guidance: reaffirmed
  - Result: reported results
  source text: On April 16, 2026, Abbott Laboratories announced its results of operations for the first quarter 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1800/000162828026025365/0001628280-26-025365-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.